439 related articles for article (PubMed ID: 14566476)
1. [Evaluation of quality of life of patients with oral squamous cell carcinoma. Comparison of two treatment protocols in a prospective study-first results].
Wiltfang J; Grabenbauer G; Bloch-Birkholz A; Leher A; Neukam FW; Kessler P
Strahlenther Onkol; 2003 Oct; 179(10):682-9. PubMed ID: 14566476
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of quality of life of patients with oral squamous cell carcinoma. Comparison of two treatment protocols in a prospective study.
Kessler PA; Bloch-Birkholz A; Leher A; Neukam FW; Wiltfang J
Radiother Oncol; 2004 Mar; 70(3):275-82. PubMed ID: 15064013
[TBL] [Abstract][Full Text] [Related]
3. [Five year survival of patients with primary oral squamous cell carcinoma. Comparison of two treatment protocols in a prospective study].
Kessler P; Grabenbauer G; Leher A; Bloch-Birkholz A; Vairaktaris E; Neukam FW; Sauer R
Strahlenther Onkol; 2007 Apr; 183(4):184-9. PubMed ID: 17406799
[TBL] [Abstract][Full Text] [Related]
4. [Patients with oral squamous cell carcinoma. Long-term survival and evaluation of quality of life-initial results obtained with two treatment protocols in a prospective study].
Kessler P; Grabenbauer G; Leher A; Schultze-Mosgau S; Rupprecht S; Neukam FW
Mund Kiefer Gesichtschir; 2004 Sep; 8(5):302-10. PubMed ID: 15309562
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant and adjuvant therapy in patients with oral squamous cell carcinoma Long-term survival in a prospective, non-randomized study.
Kessler P; Grabenbauer G; Leher A; Bloch-Birkholz A; Vairaktaris E; Neukam FW
Br J Oral Maxillofac Surg; 2008 Jan; 46(1):1-5. PubMed ID: 17931758
[TBL] [Abstract][Full Text] [Related]
6. Quality of life 2-10 years after combined treatment for advanced oral and oropharyngeal cancer.
Klug C; Neuburg J; Glaser C; Schwarz B; Kermer C; Millesi W
Int J Oral Maxillofac Surg; 2002 Dec; 31(6):664-9. PubMed ID: 12521326
[TBL] [Abstract][Full Text] [Related]
7. Disease control, survival, and functional outcome after multimodal treatment for advanced-stage tongue base cancer.
Malone JP; Stephens JA; Grecula JC; Rhoades CA; Ghaheri BA; Schuller DE
Head Neck; 2004 Jul; 26(7):561-72. PubMed ID: 15229898
[TBL] [Abstract][Full Text] [Related]
8. Preoperative radiochemotherapy and radical resection for stages II-IV oral and oropharyngeal cancer: outcome of 222 patients.
Klug C; Wutzl A; Kermer C; Voracek M; Kornek G; Selzer E; Glaser C; Poeschl PW; Millesi W; Ewers R
Int J Oral Maxillofac Surg; 2005 Mar; 34(2):143-8. PubMed ID: 15695042
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant chemotherapy for squamous cell carcinoma of the oral tongue in young adults: a case series.
Sturgis EM; Moore BA; Glisson BS; Kies MS; Shin DM; Byers RM
Head Neck; 2005 Sep; 27(9):748-56. PubMed ID: 16086413
[TBL] [Abstract][Full Text] [Related]
10. Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer.
Fung K; Lyden TH; Lee J; Urba SG; Worden F; Eisbruch A; Tsien C; Bradford CR; Chepeha DB; Hogikyan ND; Prince ME; Teknos TN; Wolf GT
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1395-9. PubMed ID: 16087298
[TBL] [Abstract][Full Text] [Related]
11. Long-term survival in locally advanced oral cavity cancer: an analysis of patients treated with neoadjuvant cisplatin-based chemotherapy followed by surgery.
Ruggeri EM; Carlini P; Pollera CF; De Marco S; Ruscito P; Pinnarò P; Nardi M; Giannarelli D; Cognetti F
Head Neck; 2005 Jun; 27(6):452-8. PubMed ID: 15880411
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL
J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant chemotherapy in squamous cell carcinoma of the esophagus using low dose continuous infusion 5-fluorouracil and cisplatin: results of a prospective study.
Aroori S; Parshad R; Kapoor A; Gupta SD; Kumar A; Chattophadyay TK
Indian J Cancer; 2004; 41(1):3-7. PubMed ID: 15105572
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant radiochemotherapy and radical resection for advanced squamous cell carcinoma of the oral cavity. Outcome of 134 patients.
Eich HT; Löschcke M; Scheer M; Kocher M; Bongartz R; Wacker S; Zöller JE; Müller RP
Strahlenther Onkol; 2008 Jan; 184(1):23-9. PubMed ID: 18188519
[TBL] [Abstract][Full Text] [Related]
15. Impact of treatment on quality of life for oral and oropharyngeal carcinoma.
Infante-Cossio P; Torres-Carranza E; Cayuela A; Hens-Aumente E; Pastor-Gaitan P; Gutierrez-Perez JL
Int J Oral Maxillofac Surg; 2009 Oct; 38(10):1052-8. PubMed ID: 19596557
[TBL] [Abstract][Full Text] [Related]
16. [Non-randomized clinical study comparing chemotherapy plus radiotherapy with radiotherapy alone in neoadjuvant therapy for oral cancer].
Kayahara H; Okuda M; Terakado N; Shintani S; Hamakawa H
Gan To Kagaku Ryoho; 2002 Jun; 29(6):911-6. PubMed ID: 12090043
[TBL] [Abstract][Full Text] [Related]
17. Influence of chemotherapy on endosteal implant survival and success in oral cancer patients.
Kovács AF
Int J Oral Maxillofac Surg; 2001 Apr; 30(2):144-7. PubMed ID: 11405450
[TBL] [Abstract][Full Text] [Related]
18. Quality of life of oral cancer patients after low-dose-rate interstitial brachytherapy.
Yoshimura R; Shibuya H; Miura M; Watanabe H; Ayukawa F; Hayashi K; Toda K
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):772-8. PubMed ID: 18676096
[TBL] [Abstract][Full Text] [Related]
19. [Histomorphological structural changes of head and neck blood vessels after pre- or postoperative radiotherapy].
Schultze-Mosgau S; Grabenbauer GG; Wehrhan F; Radespiel-Tröger M; Wiltfang J; Sauer R; Rödel F
Strahlenther Onkol; 2002 Jun; 178(6):299-306. PubMed ID: 12122785
[TBL] [Abstract][Full Text] [Related]
20. Assessment of quality of life of nasopharyngeal carcinoma patients with EORTC QLQ-C30 and H&N-35 modules.
Cengiz M; Ozyar E; Esassolak M; Altun M; Akmansu M; Sen M; Uzel O; Yavuz A; Dalmaz G; Uzal C; Hiçsönmez A; Sarihan S; Kaplan B; Atasoy BM; Ulutin C; Abacioğlu U; Demiral AN; Hayran M
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1347-53. PubMed ID: 16169671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
